Stimulation of IPF patient-derived fibroblasts with CCL2 directly increases levels of α-smooth muscle actin (α-SMA) and procollagen [32], suggesting that fibroblasts, which act as the effector cells in IPF, are another target cell affected by CCL2 (Figure 2). This evidence concerns the gene CCL2 and idiopathic pulmonary fibrosis.